a month ago
LLY
AnalystsChris SchottChris Schott's Stock Forecasts
AnalystsChris Schott
Analyst Ranking
Top 16%
#798 out of 5150 analysts
Average Return
+9.04%
Win Rate
64%52 out of 81
Risk vs Reward
Poor
Good
Chris Schott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-27 - 2024-04-26 | Strong Buy |
Eli Lilly & CoLLY | +75.50% | $458.48 | $804.62 | 2023-07-27 - 2024-07-26 | Strong Buy |
Kala Bio IncKALA | +73.24% | $205.50 | $356.00 | 2019-11-07 - 2020-11-06 | Strong Buy |
Eli Lilly & CoLLY | +71.55% | $428.44 | $734.97 | 2023-05-03 - 2024-05-03 | Strong Buy |
Heska CorpHSKA | +66.51% | $72.06 | $119.99 | 2022-10-16 - 2023-06-12 | Strong Buy |
Chris Schott Analyst Color
Get additional color on Chris Schott's coverage of popular stocks
a month ago
TEVA
a month ago
ABBV
a month ago
GILD
2 months ago
TEVA
3 months ago
GILD
3 months ago
LLY
3 months ago
AMRX
3 months ago
ABBV
4 months ago
LLY
4 months ago
IDXX
7 months ago
TEVA
10 months ago
AMRX
a year ago
LLY
a year ago
LLY
2 years ago
LLY
2 years ago
PFE
2 years ago
LLY
2 years ago
LLY
3 years ago
LLY
3 years ago
LLY
Chris Schott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 15 | Strong Buy | $1,150.00 | +11.92% | Maintains | a month ago |
Organon & CoOGN | 3 | Strong Sell | $12.00 | +67.36% | Maintains | a month ago |
Teva Pharmaceutical Industries LtdTEVA | 9 | Strong Buy | $28.00 | -6.01% | Maintains | a month ago |
Perrigo Co PLCPRGO | 6 | Hold | $20.00 | +52.21% | Downgrades | a month ago |
Zoetis IncZTS | 3 | Strong Buy | $200.00 | +68.55% | Maintains | a month ago |
Idexx Laboratories IncIDXX | 9 | Strong Buy | $775.00 | +10.05% | Maintains | a month ago |
Abbvie IncABBV | 4 | Strong Buy | $260.00 | +16.42% | Maintains | a month ago |
Gilead Sciences IncGILD | 8 | Strong Buy | $150.00 | +24.58% | Maintains | a month ago |
Elanco Animal Health IncELAN | 4 | Strong Buy | $24.00 | +12.73% | Upgrades | 2 months ago |
Amneal Pharmaceuticals IncAMRX | 3 | Strong Buy | $14.00 | +14.66% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $800.00 | +7.92% | Maintains | 6 months ago |
Biogen IncBIIB | 4 | Hold | $175.00 | +0.52% | Maintains | 7 months ago |
Royalty Pharma PLCRPRX | 4 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Amgen IncAMGN | 1 | Hold | $270.00 | N/A | Reinstates | 2 years ago |
Pfizer IncPFE | 3 | Hold | $34.00 | N/A | Maintains | 2 years ago |
Merck & Co IncMRK | 4 | Strong Buy | $125.00 | N/A | Maintains | 3 years ago |
Viatris IncVTRS | 2 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Coherus Oncology IncCHRS | 2 | Hold | $11.00 | N/A | Maintains | 3 years ago |
Eqrx IncEQRX | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Heska CorpHSKA | 2 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Bausch Health Companies IncBHC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 5 years ago |
Kala Bio IncKALA | 4 | Strong Buy | $950.00 | N/A | Maintains | 6 years ago |
Endo International PLCENDPQ | 2 | Hold | $10.00 | N/A | Maintains | 7 years ago |
Pacira Biosciences IncPCRX | 2 | Hold | $50.00 | N/A | Maintains | 7 years ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $74.00 | N/A | Maintains | 7 years ago |
Therapeuticsmd IncTXMD | 1 | Strong Buy | $550.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.